Government Bans Over-The-Counter Sale of Cough Syrups

Following amendments to the Drugs Rules, the Government of India has prohibited the over-the-counter (OTC) sale of cough syrups containing codeine and other narcotic ingredients. Only licensed pharmacists can dispense them with valid prescriptions. Lozenges, pills, and tablets for cough management remain available OTC.

BACKGROUND: This regulatory action stems from multiple public health crises, including 24 child deaths in Madhya Pradesh from adulterated cough syrup in 2025. The syrup was contaminated during manufacturing, highlighting regulatory gaps in pharmaceutical supply chains and the abuse of cough syrups containing narcotic ingredients.

KEY FACTS: The amendment restricts liquid formulations but permits solid dosage forms. Implementation applies even to villages under 1,000 population. This affects millions of pharmacy licenses and consumer access patterns.

WHY IT MATTERS FOR INDIA: Addresses pharmaceutical regulation, public health governance under Articles 47-48 of Constitution, and India's drug safety framework. Reflects concerns about narcotic abuse and counterfeit medicines.

EXAM ANGLE: UPSC Mains (Health Policy, Regulation), State PSCs (Health Administration), SSC CGL (Government Schemes). Expected questions on pharmaceutical governance, drug scheduling, NDPS Act provisions, pharmacovigilance systems, and regulatory agencies (DGCI, CDSCO). Connection to National Medicines Policy and WHO guidelines.